Genmab Announces Multiple Abstracts to be Presented at the

Media ReleaseCOPENHAGEN, Denmark; May 25, 2023 Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide (R2) in...

Related Keywords

Japan ,Netherlands ,Lugano ,Ticino ,Switzerland ,Denmark ,Chicago ,Illinois ,United States ,Germany ,New Jersey ,Copenhagen ,Køavn ,Tokyo ,American ,Judith Klimovsky ,David Freundel ,Andrew Carlsen ,Kalvebod Brygge ,European Medicines Agency ,International Conference On Malignant Lymphoma ,Abbvie Biotechnology Ltd ,Access Library ,Ministry Of Health ,Exchange Commission ,European Hematology Association ,Twitter ,Product Communications ,Meeting Library ,American Society Of Clinical Oncology ,Clinical Oncology ,Annual Meeting ,Hematology Association ,Executive Vice President ,Chief Development Officer ,International Conference ,Malignant Lymphoma ,World Evidence ,Marketing Authorization Application ,European Medicines ,Release Syndrome ,Effector Cell ,Associated Neurotoxicity Syndrome ,Prescribing Information ,Medication Guide ,Senior Director ,Vice President ,Media Release ,Annual Report ,Y Shaped Genmab ,Abbvie Biotechnology ,Copenhagen Stock Exchange Gen ,Genmaba S ,